Evidence map›Paper›PMID 29231908›Full record

ReviewMaterials (Basel, Switzerland)2017

Conjugated Polymer Nanoparticles for Bioimaging.

Yasmine Braeken, Srujan Cheruku, Anitha Ethirajan, Wouter Maes

Abstract readReview
In one paragraph

Review in Materials (Basel, Switzerland), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. The Impact of Metal Nanoparticles on Female Reproductive System: Risks and Opportunities.International journal of environmental research and public health · 2022
    Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yasmine BraekenInstitute for Materials Research (IMO-IMOMEC), Design & Synthesis of Organic Semiconductors (DSOS), UHasselt-Hasselt University, Agoralaan, 3590 Diepenbeek, Belgium. yasmine.braeken@uhasselt.be.
Srujan CherukuAssociated Lab IMOMEC, IMEC, Wetenschapspark 1, 3590 Diepenbeek, Belgium. srujan.cheruku@uhasselt.be.ORCID 0000-0001-8812-4240
Anitha EthirajanAssociated Lab IMOMEC, IMEC, Wetenschapspark 1, 3590 Diepenbeek, Belgium. anitha.ethirajan@uhasselt.be.
Wouter MaesInstitute for Materials Research (IMO-IMOMEC), Design & Synthesis of Organic Semiconductors (DSOS), UHasselt-Hasselt University, Agoralaan, 3590 Diepenbeek, Belgium. wouter.maes@uhasselt.be.ORCID 0000-0001-7883-3393

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During the last decade, conjugated polymers have emerged as an interesting class of fluorescence imaging probes since they generally show high fluorescence brightness, high photostability, fast emission rates, non-blinking behavior and low cytotoxicity. The main concern related to most conjugated polymers is their lack of hydrophilicity and thereby poor bio-availability. This can, however, be overcome by the formulation of conjugated polymer nanoparticles in aqueous medium. This review provides an overview of the different techniques employed for the preparation of conjugated polymer nanoparticles, together with methods to improve their photoluminescence quantum yields. For selective targeting of specific cells, dedicated surface functionalization protocols have been developed, using different functional groups for ligand immobilization. Finally, conjugated polymer nanoparticles have recently also been employed for theranostic applications, wherein the particles are simultaneously used as fluorescent probes and carriers for anti-tumor drugs.

Indexed as

bioimagingconjugated polymersfluorescencenanoparticles

Identifiers

PMID29231908
PMCPMC5744355

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.